NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
Back to search
Official data from USPTO
CL1870 PEPTIDE COMPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CL1870 PEPTIDE COMPLEX
ST13
US500000090845684Class
3
Filing
90845684
Registration
7295150
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
01/30/2024
Trademark type
Word
Nice classes
3
Filing date
07/23/2021
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
01/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2021
First use in commerce
08/31/2021
Drawing code
4
Owner type
16
Owner location
New York, NY
Examiner
LUEKEN, ABIGAIL
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Clinique Laboratories, LLC
Representatives
Derek Morales The Estee Lauder Companies Inc.
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated skin care preparationscosmeticscosmetic ingredient complex sold as a component in non-medicated skin care preparations
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/28/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/27/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/04/2023
EX2G
SOU EXTENSION 2 GRANTED
12/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/04/2023
EXT2
SOU EXTENSION 2 FILED
11/21/2023
IUAF
USE AMENDMENT FILED
11/21/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/21/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/21/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/28/2023
EX1G
SOU EXTENSION 1 GRANTED
01/26/2023
EXT1
SOU EXTENSION 1 FILED
01/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/26/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/29/2022
NEWN
NEW NOA TO ISSUE
10/17/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/28/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/21/2022
DOCK
ASSIGNED TO EXAMINER
04/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2021
NWAP
NEW APPLICATION ENTERED
07/27/2021
Continuous trademark protection
Get notified about every new filing that threatens CL1870 PEPTIDE COMPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.